Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Ga, Tennent"'
Autor:
Mb, Pepys, Ga, Tennent, Dr, Booth, Bellotti V, Laurence Lovat, Sy, Tan, Persey MR, Wl, Hutchinson, Se, Booth, Madhoo S, Ak, Soutar, Pn, Hawkins, Van Zyl-Smit R, Jm, Campistol, Pe, Fraser, Se, Radford, Cv, Robinson, Sunde M, Lc, Serpell, Cc, Blake
Publikováno v:
Europe PubMed Central
Amyloid deposits regress when the supply of fibril precursor proteins is sufficiently reduced, indicating that amyloid fibrils are degradable in vivo. Serum amyloid P component (SAP), a universal constituent of amyloid deposits, efficiently protects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::01e3af960530a2a6a66565f0ac41982f
https://pubmed.ncbi.nlm.nih.gov/8915605
https://pubmed.ncbi.nlm.nih.gov/8915605
Autor:
Slamova I; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Adib R; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; London Institute of Medical Sciences, Imperial College London, London, UK., Ellmerich S; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Golos MR; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; School of Biological Sciences, University of Bristol, Bristol, UK., Gilbertson JA; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Botcher N; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Canetti D; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Taylor GW; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Rendell N; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Tennent GA; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Verona G; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Porcari R; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Mangione PP; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Gillmore JD; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Pepys MB; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Bellotti V; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Hawkins PN; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Al-Shawi R; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK., Simons JP; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK. p.simons@ucl.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Dec 07; Vol. 12 (1), pp. 7112. Date of Electronic Publication: 2021 Dec 07.
Autor:
Al-Shawi R; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK., Tennent GA; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK., Millar DJ; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK., Richard-Londt A; Division of Neuropathology and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK., Brandner S; Division of Neuropathology and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK., Werring DJ; Stroke Research Group, Department of Brain Repair and Rehabilitation, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK., Simons JP; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK., Pepys MB; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, Rowland Hill Street, London NW3 2PF, UK m.pepys@ucl.ac.uk.
Publikováno v:
Open biology [Open Biol] 2016 Feb; Vol. 6 (2), pp. 150202.
Autor:
Milde R; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, 81675 Munich, Germany., Ritter J; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, 81675 Munich, Germany., Tennent GA; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London NW3 2PF, UK., Loesch A; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London NW3 2PF, UK., Martinez FO; Kennedy Rheumatology Institute, University of Oxford, Oxford OX3 7LD, UK., Gordon S; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK., Pepys MB; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London, London NW3 2PF, UK. Electronic address: m.pepys@ucl.ac.uk., Verschoor A; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, 81675 Munich, Germany; Institute for Systemic Inflammation Research, Universität zu Lübeck, 23538 Lübeck, Germany. Electronic address: admar.verschoor@uksh.de., Helming L; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, 81675 Munich, Germany.
Publikováno v:
Cell reports [Cell Rep] 2015 Dec 01; Vol. 13 (9), pp. 1937-48. Date of Electronic Publication: 2015 Nov 25.
Autor:
Mangione PP; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Deroo S; Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK., Ellmerich S; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK., Bellotti V; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy., Kolstoe S; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK., Wood SP; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK., Robinson CV; Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK., Smith MD; Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford OX1 3TA, UK., Tennent GA; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK., Broadbridge RJ; Peptide Protein Research Ltd, Claylands Road, Bishops Waltham, Southampton, Hampshire SO32 1QD, UK., Council CE; Peptide Protein Research Ltd, Claylands Road, Bishops Waltham, Southampton, Hampshire SO32 1QD, UK., Thurston JR; Peptide Protein Research Ltd, Claylands Road, Bishops Waltham, Southampton, Hampshire SO32 1QD, UK., Steadman VA; Selcia Ltd, Fyfield Road, Ongar, Essex CM5 0GS, UK., Vong AK; Selcia Ltd, Fyfield Road, Ongar, Essex CM5 0GS, UK., Swain CJ; Cambridge MedChem Consulting, 8 Mangers Lane, Duxford, Cambridge CB22 4RN, UK., Pepys MB; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK., Taylor GW; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK graham.taylor@ucl.ac.uk.
Publikováno v:
Open biology [Open Biol] 2015 Sep; Vol. 5 (9), pp. 150105.
Autor:
Rowczenio D; Department of Medicine, National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Hampstead Campus, Royal Free Campus, UCL Medical School , London , UK., Tennent GA, Gilbertson J, Lachmann HJ, Hutt DF, Bybee A, Hawkins PN, Gillmore JD
Publikováno v:
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2014 Dec; Vol. 21 (4), pp. 276-81. Date of Electronic Publication: 2014 Oct 24.
Autor:
Simons JP; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, University College London, London, UK., Loeffler JM, Al-Shawi R, Ellmerich S, Hutchinson WL, Tennent GA, Petrie A, Raynes JG, de Souza JB, Lawrence RA, Read KD, Pepys MB
Publikováno v:
Immunology [Immunology] 2014 Jul; Vol. 142 (3), pp. 414-20.
Autor:
Mangione PP; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Laboratory of Protein Crystallography, Centre for Amyloidosis and Acute Phase Proteins, and Electron Microscopy Unit, University College London, London NW3 2PF, United Kingdom., Porcari R, Gillmore JD, Pucci P, Monti M, Porcari M, Giorgetti S, Marchese L, Raimondi S, Serpell LC, Chen W, Relini A, Marcoux J, Clatworthy IR, Taylor GW, Tennent GA, Robinson CV, Hawkins PN, Stoppini M, Wood SP, Pepys MB, Bellotti V
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2014 Jan 28; Vol. 111 (4), pp. 1539-44. Date of Electronic Publication: 2014 Jan 13.
Autor:
Pepys MB; Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, Rowland Hill Street, London NW3 2PF, UK. m.pepys@ucl.ac.uk, Gallimore JR, Lloyd J, Li Z, Graham D, Taylor GW, Ellmerich S, Mangione PP, Tennent GA, Hutchinson WL, Millar DJ, Bennett G, More J, Evans D, Mistry Y, Poole S, Hawkins PN
Publikováno v:
Journal of immunological methods [J Immunol Methods] 2012 Oct 31; Vol. 384 (1-2), pp. 92-102. Date of Electronic Publication: 2012 Jul 31.
Autor:
Kolstoe SE; Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, Royal Free Campus, University College London Medical School, London NW3 2PF, United Kingdom., Mangione PP, Bellotti V, Taylor GW, Tennent GA, Deroo S, Morrison AJ, Cobb AJ, Coyne A, McCammon MG, Warner TD, Mitchell J, Gill R, Smith MD, Ley SV, Robinson CV, Wood SP, Pepys MB
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2010 Nov 23; Vol. 107 (47), pp. 20483-8. Date of Electronic Publication: 2010 Nov 08.